Rilotumumab (Anti-HGF / SF)

Rilotumumab (Anti-HGF / SF) is a monoclonal antibody that inhibits HGF/MET-driven signaling. Rilotumumab shows anti-tumor activity, and can be used in castration-resistant prostate cancer (CRPC) and solid tumor research. MW: 145.5 KD.
Supplier Selleck Chemicals
Product # A2469
Sku # A2469-1mg*5
Pricing 1mg*5, $970.00
Feedback